EVO ICL™

Font Size

Our team at New Eyes is passionate about providing you with the latest technology in the realm of ocular health. That being said, we are excited to offer the EVO ICL™, a highly sought-after treatment for mild to severe myopia (nearsightedness). To learn more about this advanced option and find out whether you qualify, we encourage you to schedule a consultation with our skilled eye surgeon, Emily Schorr, MD.

What Is the EVO ICL™?

The EVO ICL™, or “Implantable Collamer® Lens,” is an FDA-approved vision correction tool manufactured by STAAR® Surgical.* Designed to reduce dependency on glasses or contact lenses, the EVO ICL™ is placed behind the eye’s iris and in front of its natural lens in a relatively quick, minimally-invasive procedure. In the hands of a qualified eye doctor, the EVO ICL™ can vastly enhance quality of vision and reduce the severity of refractive errors, including myopia and astigmatism. Additionally, the EVO ICL™ can provide an excellent alternative for those ineligible for LASIK surgery, such as patients who suffer from dry eye syndrome.*

What Are the Benefits of the EVO ICL™?

The EVO ICL™ was developed with optimal efficiency and patient comfort in mind. Its multitude of benefits include:

The EVO ICL™ is generally best suited for patients between the ages of 21 and 45; however, everyone’s individual needs vary, and Dr. Schorr will be able to determine the best treatment for you after an in-depth consultation.

What Does the EVO ICL™ Procedure Entail?

The minimally-invasive EVO ICL™ procedure usually does not exceed 20 minutes in duration. Prior to placing the lens, Dr. Schorr will administer numbing eye drops to limit pain during treatment. From there, she will create a small opening at the base of the cornea and gently insert the lens into your eye. For safety, we ask that you have a family member or loved one drive you home.

What Can I Expect During EVO ICL™ Recovery?

In most cases, recovery from the EVO ICL™ procedure is very brief. We generally recommend you take at least a day of rest and avoid rubbing or touching your eyes as you recover, as doing so may introduce harmful bacteria. You will be prescribed additional eye drops to aid in healing, which you should use as directed.

Patients often notice an improvement in their vision as soon as the treatment is complete, but individual results may vary. In any case, you will be instructed to come in for follow-up appointments over the next few weeks so Dr. Schorr can monitor your progress.

What Risks are Associated with the EVO ICL™?

While the EVO ICL™ is widely considered very safe, certain patients may be advised to seek a different treatment depending on their individual needs. This is especially true of those who are pregnant, nursing, or suffering from moderate to severe glaucoma. Alternatively, the EVO ICL™ may not be your best option if you lack sufficient space in your anterior chamber or have an improper amount of endothelial cell density. *

Moreover, complications are rare when the lens is placed by a qualified professional. With this in mind, potential side effects include blurry vision, infection, retinal detachment, and – less commonly – an earlier development of cataracts.*

Is the EVO ICL™ Permanent?

One of the many advantages of the EVO ICL™ treatment is that it is reversible. In other words, although the lens was designed to permanently remain in the eye, it can be removed if the patient desires. In the event that you decide the EVO ICL™ is not right for you and you would like to have it removed, we advise you to seek this procedure from a highly experienced eye care professional like Dr. Schorr.

How Much Does the EVO ICL™ Cost?

While the EVO ICL™ is usually not covered by insurance, please note that our practice partners with CareCredit®, a third-party financing company with flexible plans for eligible patients. For more information about the payment process or to learn whether you qualify for CareCredit®, please visit our financial information page.

Ready to learn more about the EVO ICL™? Schedule your consultation with Dr. Schorr today.

Medical References*

STAAR® Surgical
University of Nebraska Medical Center
Review of Ophthalmology
Healthline